119th Congress · introduced in the House · Feb 12, 2025
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services relating to "Medicare Program; Calendar Year (CY) 2025 Home Health Prospective Payment System (HH PPS) Rate Update; HH Quality Reporting Program Requirements; HH Value-Based Purchasing Expanded Model Requirements; Home Intravenous Immune Globulin (IVIG) Items and Services Rate Update; and Other Medicare Policies".
Official title from Congress.gov
Latest action (Feb 12, 2025): Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
View on Congress.govPolicy area: Health
Congressional Research Service summary, version: Introduced in House (Feb 12, 2025)
This joint resolution nullifies the rule titled Medicare Program; Calendar Year (CY) 2025 Home Health Prospective Payment System (HH PPS) Rate Update; HH Quality Reporting Program Requirements; HH Value-Based Purchasing Expanded Model Requirements; Home Intravenous Immune Globulin (IVIG) Items and Services Rate Update; and Other Medicare Policies, which was issued by the Centers for Medicare & Medicaid Services on November 7, 2024.
The rule sets Medicare payment rates for 2025 for home health services, disposable negative pressure wound therapy (dNPWT) devices, and intravenous immune globulin (IVIG) items and services. It also specifies changes to reporting and participation requirements for providers of home health services and long-term care facilities under Medicare, including a requirement that long-term care facilities report additional data regarding acute respiratory illnesses.
No cosponsors.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
Administrative law and regulatory procedures · Blood and blood diseases · Cardiovascular and respiratory health · Congressional oversight · Department of Health and Human Services · Health care costs and insurance · Health technology, devices, supplies · Home and outpatient care · Long-term, rehabilitative, and terminal care · Medicare
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 24, 2026.
1 citation.
BAYADA HEARTS FOR HOMECARE · lobbying firm or registrant: BAYADA HEARTS FOR HOMECARE
2025 Q1 report (Jan 1, 2025 – Mar 31, 2025) · posted Apr 5, 2025 · issue area: Medicare/Medicaid
$20,000
Spent on own lobbying
…alizing a rule proposed by the Centers for Medicare & Medicaid Services to place certain limitations on Medicaid payments for home or community-based services. H.J.Res.58 - Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing